IVBXF
Price
$4.80
Change
-$0.06 (-1.23%)
Updated
Dec 16 closing price
MDWD
Price
$17.23
Change
-$0.04 (-0.23%)
Updated
Dec 18, 04:59 PM (EDT)
84 days until earnings call
Ad is loading...

IVBXF vs MDWD

Header iconIVBXF vs MDWD Comparison
Open Charts IVBXF vs MDWDBanner chart's image
Innovent Biologics
Price$4.80
Change-$0.06 (-1.23%)
Volume$1K
CapitalizationN/A
MediWound
Price$17.23
Change-$0.04 (-0.23%)
Volume$3.22K
CapitalizationN/A
IVBXF vs MDWD Comparison Chart
Loading...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IVBXF vs. MDWD commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVBXF is a Buy and MDWD is a StrongBuy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (IVBXF: $4.80 vs. MDWD: $17.27)
Brand notoriety: IVBXF and MDWD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IVBXF: 56% vs. MDWD: 126%
Market capitalization -- IVBXF: $7.58B vs. MDWD: $185.8M
IVBXF [@Biotechnology] is valued at $7.58B. MDWD’s [@Biotechnology] market capitalization is $185.8M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IVBXF’s FA Score shows that 0 FA rating(s) are green whileMDWD’s FA Score has 1 green FA rating(s).

  • IVBXF’s FA Score: 0 green, 5 red.
  • MDWD’s FA Score: 1 green, 4 red.
According to our system of comparison, MDWD is a better buy in the long-term than IVBXF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IVBXF’s TA Score shows that 3 TA indicator(s) are bullish while MDWD’s TA Score has 6 bullish TA indicator(s).

  • IVBXF’s TA Score: 3 bullish, 3 bearish.
  • MDWD’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, MDWD is a better buy in the short-term than IVBXF.

Price Growth

IVBXF (@Biotechnology) experienced а -1.13% price change this week, while MDWD (@Biotechnology) price change was +0.82% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

MDWD is expected to report earnings on Mar 13, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IVBXF($7.58B) has a higher market cap than MDWD($186M). MDWD YTD gains are higher at: 69.813 vs. IVBXF (-2.439).
IVBXFMDWDIVBXF / MDWD
Capitalization7.58B186M4,076%
EBITDAN/A-4.54M-
Gain YTD-2.43969.813-3%
P/E RatioN/AN/A-
RevenueN/A20.1M-
Total CashN/A29.2M-
Total DebtN/A6.36M-
FUNDAMENTALS RATINGS
MDWD: Fundamental Ratings
MDWD
OUTLOOK RATING
1..100
13
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
4
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IVBXFMDWD
RSI
ODDS (%)
Bullish Trend 7 days ago
64%
Bullish Trend 2 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
58%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
78%
MACD
ODDS (%)
Bullish Trend 2 days ago
56%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
61%
Bullish Trend 2 days ago
78%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 8 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 27 days ago
82%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
69%
Bearish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
IVBXF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MDWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMAYX41.46N/A
N/A
SEI Small Cap Growth Y (SIMT)
IDVSX24.88-0.05
-0.20%
Morgan Stanley Inst Intl Advtg R6
ABGNX20.15-0.07
-0.34%
American Century Balanced R5
BUFOX17.08-0.14
-0.81%
Buffalo Early Stage Growth Fd
AULDX104.51-3.50
-3.24%
American Century Ultra® R6

IVBXF and

Correlation & Price change

A.I.dvisor tells us that IVBXF and WXXWY have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IVBXF and WXXWY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IVBXF
1D Price
Change %
IVBXF100%
N/A
WXXWY - IVBXF
22%
Poorly correlated
-0.99%
BGNE - IVBXF
22%
Poorly correlated
+1.55%
MDWD - IVBXF
20%
Poorly correlated
+3.10%
IVEVF - IVBXF
15%
Poorly correlated
N/A
INTI - IVBXF
11%
Poorly correlated
+23.54%
More

MDWD and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDWD has been loosely correlated with PHIO. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MDWD jumps, then PHIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDWD
1D Price
Change %
MDWD100%
+3.10%
PHIO - MDWD
35%
Loosely correlated
-4.93%
AKRO - MDWD
33%
Poorly correlated
+4.72%
KANT - MDWD
30%
Poorly correlated
-14.41%
KALA - MDWD
26%
Poorly correlated
+1.31%
SYBX - MDWD
26%
Poorly correlated
-2.36%
More